These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34602362)

  • 1. Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma.
    Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
    Urol Oncol; 2021 Dec; 39(12):838.e7-838.e13. PubMed ID: 34602362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
    Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
    Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
    Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Chahoud J; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
    J Urol; 2021 Oct; 206(4):960-969. PubMed ID: 34032492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
    Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
    Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis.
    Nazzani S; Catanzaro M; Biasoni D; Maccauro M; Stagni S; Torelli T; Macchi A; Bernasconi V; Taverna A; Sessa D; Lorenzoni A; Piva L; Lanocita R; Cascella T; Cattaneo L; Montanari E; Salvioni R; Nicolai N
    Urol Oncol; 2023 Apr; 41(4):210.e1-210.e8. PubMed ID: 36868883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.
    Marconnet L; Rigaud J; Bouchot O
    J Urol; 2010 Jun; 183(6):2227-32. PubMed ID: 20399455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection?
    Naumann CM; Filippow N; Seif C; van der Horst C; Roelver L; Braun PM; Juenemann KP; Portillo FJ
    Onkologie; 2005 Mar; 28(3):135-8. PubMed ID: 15772463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
    Robinson R; Marconi L; MacPepple E; Hakenberg OW; Watkin N; Yuan Y; Lam T; MacLennan S; Adewuyi TE; Coscione A; Minhas SS; Compérat EM; Necchi A
    Eur Urol; 2018 Jul; 74(1):76-83. PubMed ID: 29703686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.
    Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S
    Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.
    Correa AF; Handorf E; Joshi SS; Geynisman DM; Kutikov A; Chen DY; Uzzo RG; Viterbo R; Greenberg RE; Smaldone MC
    J Urol; 2018 May; 199(5):1238-1244. PubMed ID: 29248557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
    Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
    BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis.
    Winters BR; Mossanen M; Holt SK; Lin DW; Wright JL
    Urology; 2016 Oct; 96():29-34. PubMed ID: 27450944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Early Inguinal Lymph Node Dissection and Neoadjuvant Chemotherapy in Penile Cancer Patient with Bulky Nodal Metastasis: A Cohort Study.
    Warli SM; Ginting JT; Sihombing B; Siregar GP; Prapiska FF
    Urol J; 2024 Feb; 21(1):47-51. PubMed ID: 37013859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.
    Woldu SL; Ci B; Hutchinson RC; Krabbe LM; Singla N; Passoni NM; Clinton TN; Raj GV; Miller DS; Sagalowsky AI; Lotan Y; Xie Y; Margulis V; Bagrodia A
    Urol Oncol; 2018 Apr; 36(4):159.e7-159.e17. PubMed ID: 29288008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection.
    Chipollini J; Azizi M; Lo Vullo S; Mariani L; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ager M; Hakenberg O; Heidenreich A; Raggi D; Catanzaro M; Ornellas P; Salvioni R; Cheriyan SK; Necchi A; Spiess PE
    BJU Int; 2020 Jan; 125(1):82-88. PubMed ID: 31356716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
    Heyns CF; Theron PD
    BJU Int; 2008 Aug; 102(3):305-9. PubMed ID: 18410439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-port robotic inguinal lymph node dissection: A safe and feasible option for penile cancer.
    Patel AS; Isharwal S
    Surg Oncol; 2021 Sep; 38():101633. PubMed ID: 34332496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma.
    Bandini M; Albersen M; Chipollini J; Pederzoli F; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ager M; Hakenberg OW; Heidenreich A; Raggi D; Catanzaro M; Haidl F; Mazzone E; Marandino L; Briganti A; Montorsi F; Azizi M; Spiess PE; Necchi A
    BJU Int; 2020 Jun; 125(6):867-875. PubMed ID: 32175663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
    Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
    Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.